Your 92 Expert Speakers

Ahmed Bassyouni

Independent Consultant

Amy Han

Solid Tumor Targeted Therapies & Commercial Disease Area Leader

Regeneron

Andreas Pahl

Chief Scientific Officer

Heidelberg Pharma

Andrew Philips

Director of Next Generation Drug Conjugates

AbbVie

Ann MacLaren

Executive Director, Translational Development

Triphase Accelerator

Anthony (Tony) Polverino

Executive Vice President, Early Development & Chief Scientific Officer

Zymeworks

Anton Rosembaum

Head of Regulated Bioanalysis & OMICS by LC-MS within Integrated Bioanalysis

AstraZeneca

Antonio Palumbo

MD Global Medical Expert

GlaxoSmithKline

Aubrey Morgart

ADC Patient

Audrey Bendelac

ADC Scientific Manager, Process Development

Sanofi

Ben-Quan Shen

Principal Scientist

Genentech

Brian Clark

Independant Consultant

GMP Consulting

Brian Mendehlson

Senior Director

Exelixis

Brian O’Mara

Associate Director - Downstream Process Development

Ambrx

Brian Safina

Vice President – Chemistry

Bolt Biotherapeutics

Chee Ng

Associate Professor & Research Investigator

University of Kentucky

Chet Bohac

Senior Medical Director

Macrogenics

Chris Scott

Professor - Pharmaceutical Biosciences

Queen’s University Belfast

Christian Behrenbruch

Managing Director & Chief Executive Officer

Telix Pharmaceuticals

Christine Knuehl

TBR Lead

Merck

Daisuke Okajima

Scientist, Preclinical Pharmacology, Oncology

Daiichi Sankyo

Daniel Custar

Associate Director - Drug Substance, Chemistry, Manufacturing & Controls

Mersana

David Lyon

Senior Fellow, Research Lonza Pharma & Biotech

Lonza

David Newman

Independent Consultant

Donald Mager

Professor & Vice Chair of Pharmaceutical Sciences

University at Buffalo

Dong Wei

Associate Director - Bioanalytical, Biomarker, Drug Metabolism & Pharmacokinetics

Takeda

Earl Albone

Senior Director, Biochemistry Discovery

Eisai

Ed Ha

Founding Principal Scientist - Antibody Drug Conjugates

AngieX

Emily Stevens

Medical Director of Tactical Biomarker Team

Seagen

Emmett Schmidt

Vice President, Clinical Research, Lead, External Collaborations, Oncology Early Development

Merck

Engin Ayturk

Director - Chemistry Manufacturing & Control Process Engineering & Bioconjugation

Mersana

Federico Riccardi Sirtori

Director, Head of NBE-DMPK Innovative Bioanalytics

Merck KGaA

Gail Lewis Philips

Senior Scientist, Discovery Oncology

Genentech

Ganapathy Sarma

Director - Chemistry

Bolt Biotherapeutics

Gang Yao

Director, Head of Novel Modalities R&D

MilliporeSigma

Germo Gericke

Senior Vice President - Research & Development & Chief Medical Officer

Advanced Accelerator Applications

Gilles Gallant

Senior Vice President, Global Head of Oncology Development, Oncology R&D

Daiichi Sankyo

Giorgio Salciarini

Senior Manager – Technical, Business Development

BSP Pharmaceuticals

Greg Thurber

Associate Professor

University of Michigan

Hillary Shcuessler

Scientific Leader

GlaxoSmithKline

Hirdesh Uppal

Vice President, Head of Development Sciences

CytomX

Jay Harper

Associate Director - Research Onocology

AstraZeneca

Jia He

Senior Research Analyst

Beacon Targeted Therapies

John Lambert

Independent Consultant

Attager Consulting

John Rolf

Director, Product Quality

Seagen

John Valliere Douglass

Associate Director

Seagen

Jun Tang

Senior Direcctor, Business Development

Henlius

Justin Oh

Chief Business Officer

AbTis

Leo Nicacio

Vice President - Clinical Development

Seagen

Lisa Mcdermott

Director - Process, Analytical Development & Senior Manager

Millipore Sigma

Louie Namouvski

Group Medical director

AbbVie

Marc Damelin

Vice President, Biology

Mersana

Marie Zhu

Chief Technology Officer

Remegen

Martha Neagu

Associate Medical Director - Physician Development Program

AbbVie

Martyn Ryder

Director

ILC Dover

Megan O’Meara

Vice President, Head of Early Stage Development

Seagen

Michael J. Roberts

Scientific Consultant

NOF America Corporation

Mingchao Kang

Project Leader, EuCode

Ambrx

Minmin Qin

Senior Vice President of CMC

Miracogen

Naresh Jain

President & Chief Executive Officer

NJ Bio

Nathan Tumey

Assistant Professor, Pharmaceutical Sciences

Binghamton University

Neil Bander

Professor, Bernard and Josephine Chaus Chair in Urological Oncology, & Director of Urological Oncology Research

Weill Cornell Medicine

Nicola Stagg

Senior Scientist - Toxicologist & Toxicology Oncology Therapeutic Area Lead

Genentech

Patrick Groothuis

Principal Scientist - In Vivo Pharmacology, Toxicology, Drug Metabolism & Pharmacokinetics

Byondis

Paul Song

Chief Scientific Officer

Genequantum

Philip Howard

Chief Scientific Officer

Spirogen

Prathap Mahalingaiah

Senior Scientist - Research, Investigative Toxicology, Pathology & Global Preclinical Safety

Abbvie

Puja Sapra

Vice President, Head of Tumor Targeted Delivery, Oncology R&D

AstraZeneca

Rakesh Dixit

President & Founder

Bionavigen

Raphael Eric Steiner

Assistant Professor in the Department of Lymphoma & Myeloma

University of Texas MD Anderson Cancer Center

Rob Straubinger

Professor of Pharmaceutical Sciences

University at Buffalo

Robert Herbst

Executive Director – Technical Operations

ImmunoGen

Robert Lutz

Chief Science Officer

Iksuda

Robert Sussman

Managing Director

SafeBridge Regulatory & Life Sciences Group

Roger Beerli

Chief Scientific Officer

NBE-Therapeutics

Rolf Werner

Chief Operation Officer

Genequantum Healthcare Co Ltd

Ruud Coumans

Project Leader Antibody-Drug Conjugates

Byondis

Sabra Hanspal

Senior Scientist

AbbVie CMO

Scott Patterson

Vice President, Technical Support

ILC Dover

Scott Tagawa

Professor of Medicine & Professor of Medicine in Urology

Weill Cornell Medicine

Sean Smith

Executive Director of Chemistry

Silverback Therapeutics

Seema Kantak

Vice President, Biologics & Biotherapeutics

Exelixis

Sudhir Penugonda

Medical Director, Oncology Early Development

AbbVie

Sukumar Sakamuri

Vice President, Head of Chemistry

Ambrx

Susan Clardy

Senior Scientist - Analytical Chemistry, Manufacturing & Control

Mersana

Tae Kyo Park

Chief Executive Officer

Intocell

Tim Lowinger

Chief Scientific Officer

Mersana

Ty Davis

Investigator

GlaxoSmithKline

Valerie Odegard

President & Chief Scientific Officer

Silverback Therapeutics

Victor Yip

Principal Scientific Researcher

Genentech

Viola Chen

Senior Medical Director, Oncology

Merck

Violet Lee

Scientist

Genentech

Xinfang Li

Vice President - Process Development & Head of Chemistry, Manufacturing & Controls

Mabplex

Yutaka Matsuda

ADC Researcher

Ajinomoto Bio- Pharma Services

Yuyi Shen

Associate Director Process Development & Manufacturing

Bolt Biotherapeutics

Zhala Tawfig

Process Development & TT Associate Scientist

Ajinomoto Bio- Pharma Services